XML 29 R18.htm IDEA: XBRL DOCUMENT v3.20.2
DERIVATIVE FINANCIAL INSTRUMENTS
9 Months Ended
Sep. 30, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
DERIVATIVE FINANCIAL INSTRUMENTS

NOTE 10 - DERIVATIVE FINANCIAL INSTRUMENTS

The Company utilizes certain derivative financial instruments. Stand-alone derivative financial instruments such as interest rate swaps, are used to economically hedge interest rate risk related to the Company’s liabilities. These derivative instruments involve both credit and market risk. The notional amounts are amounts on which calculations, payments, and the value of the derivative are based. Notional amounts do not represent direct credit exposures. Direct credit exposure is limited to the net difference between the calculated amounts to be received and paid, if any. Such difference, which represents the fair value of the derivative instruments, is reflected on the Company’s consolidated balance sheets in other liabilities.

The Company is exposed to credit related losses in the event of nonperformance by the counterparties to those agreements. The Company controls the credit risk of its financial contracts through credit approvals, limits and monitoring procedures, and does not expect any counterparties to fail to perform their respective obligations.

The Company entered into interest rate swaps to receive payments at a fixed rate in exchange for paying a floating rate on the debentures discussed in Note 5. Management believes that entering into the interest rate swaps exposed the Company to variability in their fair value due to changes in the level of interest rates. It is the Company’s objective to hedge the change in fair value of floating rate debentures at coverage levels that are appropriate, given anticipated or existing interest rate levels and other market considerations, as well as the relationship of change in this liability to other liabilities of the Company.

The Company also entered into interest rate swaps to receive payments at a floating rate in exchange for paying a fixed rate, the objective of which is to reduce the overall cost of short-term 3-month FHLB advances that will be renewed consistent with the reset terms on the interest rate swap and that are included in the amounts in Note 4.

Interest rate swaps with notional amounts totaling $5,000 as of September 30, 2020 and December 31, 2019, were designated as cash flow hedges of the debentures and $40,000 as of September 30, 2020 were designated as cash flow hedges of the FHLB advances.

The aggregate fair value of the swaps is recorded in accrued interest and other liabilities within the Company’s consolidated balance sheets with changes in fair value recorded in other comprehensive income.

The information pertaining to outstanding interest rate swap agreements used to hedge floating rate debentures and FHLB advances was as follows as of:

 

September 30, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notional

Amount

 

 

Pay

Rate

 

 

Receive

Rate

 

Effective

Date

 

Maturity

in Years

 

 

Unrealized

Losses

 

$

2,000

 

 

 

5.979

%

 

3 month LIBOR plus 1.67%

 

10/1/2016

 

 

5.50

 

 

$

440

 

$

3,000

 

 

 

7.505

%

 

3 month LIBOR plus 3.35%

 

10/30/2012

 

 

2.08

 

 

$

249

 

$

15,000

 

 

 

0.668

%

 

3 month LIBOR

 

3/18/2020

 

 

2.47

 

 

$

164

 

$

15,000

 

 

 

0.790

%

 

3 month LIBOR

 

3/18/2020

 

 

4.47

 

 

$

328

 

$

10,000

 

 

 

0.530

%

 

3 month LIBOR

 

3/23/2020

 

 

2.48

 

 

$

75

 

 

December 31, 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notional

Amount

 

 

Pay

Rate

 

 

Receive

Rate

 

Effective

Date

 

Maturity

in Years

 

 

Unrealized

Losses

 

$

2,000

 

 

 

5.979

%

 

3 month LIBOR plus 1.67%

 

10/1/2016

 

 

6.25

 

 

$

314

 

$

3,000

 

 

 

7.505

%

 

3 month LIBOR plus 3.35%

 

10/30/2012

 

 

2.83

 

 

$

212

 

 

Interest expense recorded on these swap transactions totaled $509 and $495 during the nine months ended September 30, 2020 and 2019, respectively. This expense is reported as a component of interest expense on the debentures and the FHLB advances and federal funds purchased. At September 30, 2020, the Company expected none of the unrealized loss to be reclassified as a reduction of interest expense during the remainder of 2020.